Metabolomics Market 2020 Outlook, Opportunity and Demand Analysis Report by TBRC

LONDON, March 26, 2020 /PRNewswire/ -- TheBusinessResearchCompany.com offers "Global Metabolomics Market Report 2020" from its latest research database. The report talks about the major players involved in this industry and ready available for purchase.

Adoption Of Machine Learning In The $1.7 Billion Metabolomics Market

Machine learning is increasing its popularity in the field of metabolomics due to improved efficiency in interpretation of data generated from metabolomics techniques. Machine learning enabled technologies help in automation of risky and complex processes, avoid repetitive and time taking processes, and provide quick and error-free services. Companies in the industry are preferring machine learning techniques for metabolism analysis to solve problems, automate processes and execute tasks. Some of the machine learning algorithms aid in metabolism data analysis and metabolic pathway modeling. Companies such as Bio-Rad Laboratories, Metabolon Inc. and others have started using machine learning algorithms for better understanding and prediction in metabolomics study. For instance, MeltDB 2.0 is a machine learning software used as a tool for the analysis and integration of metabolomics experiment data, that aids research and stores experimental data sets. Such machine learning software offer comprehensive analysis and visualization features for the proper representation of the large complex data.

Read More On The Business Research Company's Metabolomics Market Report:

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Metabolomics is the field of bio-analytics for quantification and identification of metabolic small molecules such as cell, tissue, organ and biological fluid. Metabolomics includes analytical instruments such as liquid chromatography, gas chromatography, capillary electrophoresis, mass spectrometry and nuclear magnetic resonance spectroscopy.

Metabolomics As A Tool For Early Detection And Cure For Cancer

Increasing prevalence rate of cancer drives the metabolomics market growth. The global metabolomics market was valued at about $1.7 billion in 2018 and is expected to grow to $2.83 billion at a compound annual growth rate (CAGR) of 13.6% through 2022.

Metabolomics screen the potential biomarkers (specific cells, molecules, or genes, gene products, enzymes, or hormones) to measure the cancer drug responsiveness aiding early diagnosis. For instance, according to a report by the American Cancer Society in 2018, approximately 1,735,350 new cancer cases were diagnosed in the United States, of which the most common cancers were lung cancer, breast cancer, prostate cancer, and others. In 2018, according to the American Lung Association, lung cancer is the leading cancer killer in both men and women in the USA; there were 2.1 million new cancer cases and 1.8 million deaths. Metabolomics' approaches such as nuclear magnetic resonance (NMR) technique and mass spectrometry (MS) techniques have been used to study cancer. Companies like Metabolon Inc., Bruker Corp, and others have adopted metabolomics as a tool for early detection and cure for cancer.

Difficulties In Interpretation Of Complex Data Restrain The Metabolomics Market Growth

The increasing complexity in interpreting data acts as a restraining factor, thus hindering the metabolomics market growth. Metabolomics tools generate huge quantum of data through metabolomics techniques. The generated data keeps changing and is not static, hence increasing the difficultly in interpretation of data. For instance, data generated by nuclear magnetic resonance (NMR) Spectroscopy, an analytical technique used for metabolic profiling (a method to measure and interpret various low molecular weight and other intermediates), is difficult to process and interpret. High-level statistical techniques are required for classification and analysis of this data to uncover the biological knowledge, which is time-consuming and expensive. This restrains the metabolomics market growth.

Request A Sample Of The Metabolomics Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

Biocrates Life Sciences Acquires Metanomics Health

Major players in the metabolomics market are Human Metabolome Technologies, Metabolon, Bio-Rad Laboratories, Bruker, and Agilent Technologies. Companies in the market have been investing in mergers and acquisitions to strengthen their businesses. In January 2018, Biocrates Life Sciences AG, an Austria-based biotechnology company, acquired Metanomics Health GmbH, for an undisclosed amount. This acquisition would strengthen and improve Biocrates Life's market share in early disease detection, by leveraging the capabilities of Metanomics. Metanomics Health GmbH is a biotechnology company offering metabolomics in life sciences and providing analytical services of metabolite profiling It is also involved in marketing and developing tools to carry out research and development in the healthcare sector. The company was founded in 2002 and is headquartered in Berlin, Germany.

Here Is A List Of Similar Reports By The Business Research Company:

Sequencing Market By Type (Next Generation Sequencing, Third Generation Sequencing And Sanger Sequencing), By Products (Consumables, Software, Sequencing Services And Instruments), By Regions And By Trends – Global Forecast To 2023

Metabolic Disorders Drugs Global Market Report 2020

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information

The Business Research Company 
Europe: +44-207-1930-708
Asia: +91-8897263534
Americas: +1-315-623-0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_Info

SOURCE The Business Research Company